SCHEMBL19794370

SCHEMBL19794370

c1ccc(-c2ccc(-c3ccc(-c4ccccc4-c4cc(-c5ccccc5-c5ccc(-c6ccc(-c7ccccc7)cc6)nc5)cc(-c5ccccc5-c5ccc(-c6ccc(-c7ccccc7)cc6)nc5)c4)cn3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 2/20 0.50
HPGDS O60760 1/20 0.49
HSD17B1 P14061 1/20 0.49
HSD17B2 P37059 1/20 0.49
CYP11B1 P15538 4/20 0.45
CYP11B2 P19099 4/20 0.45
USP7 Q93009 1/20 0.44
BAZ2B Q9UIF8 1/20 0.44
NPC1 O15118 1/20 0.42
NFKB1 P19838 1/20 0.42
RAB9A P51151 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PTPN2 P17706 1/20 0.41
PTPN1 P18031 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41
GABRA5 P31644 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19794431 1.00 LDHA (0.50) LDHAHPGDSHSD17B1HSD17B2CYP11B1
SCHEMBL18015495 1.00 LDHA (0.50) LDHAHPGDSHSD17B1HSD17B2CYP11B1
SCHEMBL18015574 0.98 LDHA (0.52) LDHAHPGDSHSD17B1HSD17B2CYP11B1
SCHEMBL19933578 0.98 LDHA (0.52) LDHAHPGDSHSD17B1HSD17B2CYP11B1
SCHEMBL21721920 0.96 LDHA (0.50) LDHAHPGDSHSD17B1HSD17B2CYP11B1
SCHEMBL23956290 0.95 HSD17B1 (0.57) LDHAHPGDSHSD17B1HSD17B2CYP11B1
SCHEMBL19794434 0.95 HSD17B1 (0.57) LDHAHPGDSHSD17B1HSD17B2CYP11B1
SCHEMBL23239870 0.95 HSD17B1 (0.57) LDHAHPGDSHSD17B1HSD17B2CYP11B1
SCHEMBL21125931 0.94 HSD17B1 (0.56) LDHAHPGDSHSD17B1HSD17B2CYP11B1
SCHEMBL18015479 0.93 HSD17B1 (0.59) LDHAHPGDSHSD17B1HSD17B2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 US disclosed
EP-3254317-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-31 EP disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC LDHA 2726/4885HPGDS 4832/4885HSD17B1 4860/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 LDHA 1917/4885HPGDS 4844/4885HSD17B1 4527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.